ZA983729B - B-ring estratriene diols. - Google Patents

B-ring estratriene diols.

Info

Publication number
ZA983729B
ZA983729B ZA9803729A ZA983729A ZA983729B ZA 983729 B ZA983729 B ZA 983729B ZA 9803729 A ZA9803729 A ZA 9803729A ZA 983729 A ZA983729 A ZA 983729A ZA 983729 B ZA983729 B ZA 983729B
Authority
ZA
South Africa
Prior art keywords
estratriene
diols
ring
ring estratriene
estratriene diols
Prior art date
Application number
ZA9803729A
Other languages
English (en)
Inventor
Michael Z Kagan
Panolil Raveendranath
Syed Muzafar Shah
Michael William Winkley
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ZA983729B publication Critical patent/ZA983729B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9803729A 1997-05-05 1998-05-04 B-ring estratriene diols. ZA983729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84188297A 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
ZA983729B true ZA983729B (en) 1999-11-04

Family

ID=25285939

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9803729A ZA983729B (en) 1997-05-05 1998-05-04 B-ring estratriene diols.

Country Status (17)

Country Link
EP (1) EP0983294B1 (xx)
JP (1) JP2001526654A (xx)
KR (1) KR20010012274A (xx)
CN (1) CN1255142A (xx)
AR (1) AR014871A1 (xx)
AT (1) ATE230756T1 (xx)
AU (1) AU750306B2 (xx)
BR (1) BR9809592A (xx)
CA (1) CA2289011A1 (xx)
DE (1) DE69810617T2 (xx)
DK (1) DK0983294T3 (xx)
ES (1) ES2187966T3 (xx)
HK (1) HK1025577A1 (xx)
PT (1) PT983294E (xx)
TW (1) TW464653B (xx)
WO (1) WO1998050414A1 (xx)
ZA (1) ZA983729B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004524354A (ja) * 2001-03-16 2004-08-12 ワイス エストロゲン補充療法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE635781C (de) * 1934-10-14 1936-10-02 Merck Ag E Verfahren zur Herstellung von Abbauprodukten des Neoergosterins
GB864231A (en) * 1958-08-07 1961-03-29 Glaxo Lab Ltd Improvements in or relating to the preparation of steroids

Also Published As

Publication number Publication date
ES2187966T3 (es) 2003-06-16
BR9809592A (pt) 2000-07-04
CA2289011A1 (en) 1998-11-12
CN1255142A (zh) 2000-05-31
AR014871A1 (es) 2001-04-11
HK1025577A1 (en) 2000-11-17
KR20010012274A (ko) 2001-02-15
AU750306B2 (en) 2002-07-18
EP0983294A1 (en) 2000-03-08
DK0983294T3 (da) 2003-02-24
EP0983294B1 (en) 2003-01-08
JP2001526654A (ja) 2001-12-18
PT983294E (pt) 2003-04-30
WO1998050414A1 (en) 1998-11-12
TW464653B (en) 2001-11-21
DE69810617T2 (de) 2003-10-02
AU7261198A (en) 1998-11-27
ATE230756T1 (de) 2003-01-15
DE69810617D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
HK1026383A1 (en) Supported diols
HK1026029A1 (en) Timepiece.
CY2325B1 (en) Estrogenic agents.
CY2410B1 (en) Novel device.
HK1016976A1 (en) Resorcinyl-triazine.
HK1018801A1 (en) Tilting-bowl toilet.
ZA981926B (en) Detergent--package combination.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA98387B (en) Novel microorganisms.
GB2327817B (en) Fan
HK1024098A1 (en) Radio architecture.
HK1017834A1 (en) Bodyshaper.
HK1028108A1 (en) Timepiece.
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA983729B (en) B-ring estratriene diols.
GB9718940D0 (en) D. D. mat
ZA983688B (en) B-ring estratrienes.
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
PL341103A1 (en) Fan
ZA983702B (en) Pregnane 3,20 diols.
ZA978504B (en) Assay.
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.
ZA983685B (en) Pregnanes.